Ajanta Pharma gets US FDA observations after inspection at Dahej facility
United States Food and Drug Administration issued Form 483 to Ajanta Pharma limited after the successful completion of its audit of Ajanta Pharma's Dahej facility
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
